Journal Article
. 2020 Nov; 10:515421.
doi: 10.3389/fonc.2020.515421.

Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer

Xuemei Yang 1 Juan Li 1 Yifan Wang 1 Peilong Li 1 Yinghui Zhao 1 Weili Duan 1 Abakundana Nsenga Ariston Gabriel 1 Yingjie Chen 1 Haiting Mao 1 Yunshan Wang 1 Lutao Du 1 Chuanxin Wang 1 
Affiliations
  • PMID: 33194577
  •     49 References

Abstract

Deregulations of long non-coding RNAs (lncRNAs) have been implicated in the progression of breast cancer (BC). However, the prognostic values of those lncRNAs in BC remain elusive. This study aimed at constructing a lncRNA-based prognostic model to improve the clinical management of BC. Systematic investigation of lncRNA expression profiles and clinical data from The Cancer Genome Atlas (TCGA) database were utilized to establish a 10-lncRNA signature. The prognostic signature efficiently discriminated patients with significantly different prognosis regardless of intrinsic molecular subtypes and tumor-node-metastasis (TNM) stage. A combined model was constructed by multivariate Cox proportional hazards regression (CPHR) analysis, which combined the lncRNA-based signature with certain clinical risk factors (TNM stage, age, and human epidermal growth factor receptor 2 status). This model predicted a survival probability that closely corresponds to the actual survival probability. With respect to the entire set, the time-dependent receiver-operating characteristic curves revealed that the area under the curve of this model was the highest than any of the clinical risk factors. Moreover, functional enrichment analysis indicated that the molecular signature was mainly involved in DNA replication, which was firmly related to BC tumorigenesis. Consistent with the discovery, the knockdown of LHX1-DT, one of the 10 prognostic lncRNAs, attenuated the proliferation of BC cells in vitro and in vivo. Taken together, our study constructed a novel 10-lncRNA signature for prediction prognosis, and the signature-based model could provide new insight into accurate management of BC patients.

Keywords: breast cancer; long non-coding RNA; nomogram; prognosis; signature.

LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.
Jiagen Li, Zhaoli Chen, +24 authors, Jie He.
Gut, 2014 Feb 14; 63(11). PMID: 24522499    Free PMC article.
Highly Cited.
Integrating of genomic and transcriptomic profiles for the prognostic assessment of breast cancer.
Chengxiao Yu, Na Qin, +7 authors, Yue Jiang.
Breast Cancer Res Treat, 2019 Mar 15; 175(3). PMID: 30868394
Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal.
CA Cancer J Clin, 2020 Jan 09; 70(1). PMID: 31912902
Highly Cited.
A novel six-microRNA-based model to improve prognosis prediction of breast cancer.
Jianguo Lai, Hongli Wang, Zihao Pan, Fengxi Su.
Aging (Albany NY), 2019 Jan 31; 11(2). PMID: 30696800    Free PMC article.
Clinicopathological classification and traditional prognostic indicators of breast cancer.
Jiehua Li, Zhibai Chen, Ka Su, Jian Zeng.
Int J Clin Exp Pathol, 2015 Sep 05; 8(7). PMID: 26339424    Free PMC article.
Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases.
Yun Zhang, Shunbin Xiong, +9 authors, Guillermina Lozano.
Nat Commun, 2018 Sep 29; 9(1). PMID: 30262850    Free PMC article.
High LINC00536 expression promotes tumor progression and poor prognosis in bladder cancer.
Ran Li, Lei Zhang, +5 authors, Long Ma.
Exp Cell Res, 2019 Mar 10; 378(1). PMID: 30851243
LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer.
Shurui Ouyang, Xin Zhou, +3 authors, Ming Xie.
Cancer Cell Int, 2019 Apr 10; 19. PMID: 30962766    Free PMC article.
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
A Gordon Robertson, Jaegil Kim, +40 authors, Seth P Lerner.
Cell, 2017 Oct 11; 171(3). PMID: 28988769    Free PMC article.
Highly Cited.
Four lncRNAs associated with breast cancer prognosis identified by coexpression network analysis.
Jie Li, Chundi Gao, +12 authors, Changgang Sun.
J Cell Physiol, 2019 Jan 09; 234(8). PMID: 30618123
Regulation of Neuroregeneration by Long Noncoding RNAs.
Rotem Ben-Tov Perry, Hadas Hezroni, Micah Jonathan Goldrich, Igor Ulitsky.
Mol Cell, 2018 Nov 08; 72(3). PMID: 30401432    Free PMC article.
Considerations when investigating lncRNA function in vivo.
Andrew R Bassett, Asifa Akhtar, +10 authors, Chris P Ponting.
Elife, 2014 Aug 16; 3. PMID: 25124674    Free PMC article.
Highly Cited. Review.
SNHG15: a promising cancer-related long noncoding RNA.
Jinfei Tong, Xudong Ma, Hailan Yu, Jianhua Yang.
Cancer Manag Res, 2019 Jul 17; 11. PMID: 31308739    Free PMC article.
Review.
Discovery, Annotation, and Functional Analysis of Long Noncoding RNAs Controlling Cell-Cycle Gene Expression and Proliferation in Breast Cancer Cells.
Miao Sun, Shrikanth S Gadad, Dae-Seok Kim, W Lee Kraus.
Mol Cell, 2015 Aug 04; 59(4). PMID: 26236012    Free PMC article.
Highly Cited.
Plasma long noncoding RNAs PANDAR, FOXD2-AS1, and SMARCC2 as potential novel diagnostic biomarkers for gastric cancer.
Ziwei Yang, Yanfei Sun, +2 authors, Shigang Ding.
Cancer Manag Res, 2019 Jul 17; 11. PMID: 31308753    Free PMC article.
Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafish.
Adriana Rodríguez-Marí, Catherine Wilson, +11 authors, John H Postlethwait.
PLoS Genet, 2011 Apr 13; 7(3). PMID: 21483806    Free PMC article.
Cancer treatment and survivorship statistics, 2016.
Kimberly D Miller, Rebecca L Siegel, +6 authors, Ahmedin Jemal.
CA Cancer J Clin, 2016 Jun 03; 66(4). PMID: 27253694
Highly Cited.
Essential TNM: a registry tool to reduce gaps in cancer staging information.
Marion Piñeros, D Maxwell Parkin, +10 authors, James Brierley.
Lancet Oncol, 2019 Feb 05; 20(2). PMID: 30712797
Review.
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.
Junjie Tony Hua, Musaddeque Ahmed, +20 authors, Housheng Hansen He.
Cell, 2018 Jul 24; 174(3). PMID: 30033362
Highly Cited.
Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer.
Yuying Han, Qiyu Zheng, +2 authors, Haihong Ye.
J Surg Oncol, 2019 Mar 20; 119(8). PMID: 30887516
Integrated genomic and molecular characterization of cervical cancer.
Cancer Genome Atlas Research Network, Albert Einstein College of Medicine, +54 authors, Washington University in St Louis.
Nature, 2017 Jan 24; 543(7645). PMID: 28112728    Free PMC article.
Highly Cited.
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Hege O Ohnstad, Elin Borgen, +11 authors, Bjørn Naume.
Breast Cancer Res, 2017 Nov 16; 19(1). PMID: 29137653    Free PMC article.
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Fatima Cardoso, Laura J van't Veer, +32 authors, MINDACT Investigators.
N Engl J Med, 2016 Aug 25; 375(8). PMID: 27557300
Highly Cited.
Comprehensive bioinformatics analysis reveals potential lncRNA biomarkers for overall survival in patients with hepatocellular carcinoma: an on-line individual risk calculator based on TCGA cohort.
Zhiqiao Zhang, Yanling Ouyang, +4 authors, Qingbo Liu.
Cancer Cell Int, 2019 Jul 18; 19. PMID: 31312112    Free PMC article.
LncRNA BCAR4 up-regulates EGFR and thus promotes human thyrocyte proliferation.
H Y Zhai, R H Yan, +3 authors, J Li.
Neoplasma, 2018 Dec 21; 66(2). PMID: 30569716
Antisense lncRNA Transcription Mediates DNA Demethylation to Drive Stochastic Protocadherin α Promoter Choice.
Daniele Canzio, Chiamaka L Nwakeze, +9 authors, Tom Maniatis.
Cell, 2019 Apr 09; 177(3). PMID: 30955885    Free PMC article.
Highly Cited.
The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression.
Thomas Derrien, Rory Johnson, +24 authors, Roderic Guigó.
Genome Res, 2012 Sep 08; 22(9). PMID: 22955988    Free PMC article.
Highly Cited.
Technological Developments in lncRNA Biology.
Sonali Jathar, Vikram Kumar, Juhi Srivastava, Vidisha Tripathi.
Adv Exp Med Biol, 2017 Aug 18; 1008. PMID: 28815544
Review.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +28 authors, George W Sledge.
N Engl J Med, 2015 Sep 29; 373(21). PMID: 26412349    Free PMC article.
Highly Cited.
Deregulated Expression of Mammalian lncRNA through Loss of SPT6 Induces R-Loop Formation, Replication Stress, and Cellular Senescence.
Takayuki Nojima, Michael Tellier, +7 authors, Nick J Proudfoot.
Mol Cell, 2018 Nov 20; 72(6). PMID: 30449723    Free PMC article.
BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance.
Zhiping Cai, Yapei Wu, +2 authors, Linhui Wang.
Aging (Albany NY), 2018 Dec 05; 10(12). PMID: 30513511    Free PMC article.
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling.
Jie Luo, Keliang Wang, +9 authors, Chawnshang Chang.
Nat Commun, 2019 Jun 14; 10(1). PMID: 31189930    Free PMC article.
Highly Cited.
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
Norman Sachs, Joep de Ligt, +28 authors, Hans Clevers.
Cell, 2017 Dec 12; 172(1-2). PMID: 29224780
Highly Cited.
Breast Cancer Treatment: A Review.
Adrienne G Waks, Eric P Winer.
JAMA, 2019 Jan 23; 321(3). PMID: 30667505
Highly Cited. Review.
How to build and interpret a nomogram for cancer prognosis.
Alexia Iasonos, Deborah Schrag, Ganesh V Raj, Katherine S Panageas.
J Clin Oncol, 2008 Mar 08; 26(8). PMID: 18323559
Highly Cited. Review.
Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
Fangyao Chen, Zhe Li, Changyu Deng, Hong Yan.
J Cell Biochem, 2019 Jul 05; 120(12). PMID: 31271223
An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment.
Jianing Tang, Qiuxia Cui, +3 authors, Gaosong Wu.
J Cell Mol Med, 2019 May 28; 23(8). PMID: 31124293    Free PMC article.
Genome-wide identification of lncRNAs as novel prognosis biomarkers of glioma.
Lianhao Song, Shengkun Zhang, +4 authors, Ming Chu.
J Cell Biochem, 2019 Jul 13; 120(12). PMID: 31297871
A 17-marker panel for global genomic instability in breast cancer.
Jana Biermann, Szilárd Nemes, +5 authors, Khalil Helou.
Genomics, 2019 Jul 02; 112(2). PMID: 31260745
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.
Paz Polak, Jaegil Kim, +25 authors, Gad Getz.
Nat Genet, 2017 Aug 22; 49(10). PMID: 28825726    Free PMC article.
Highly Cited.
Long noncoding RNAs: cellular address codes in development and disease.
Pedro J Batista, Howard Y Chang.
Cell, 2013 Mar 19; 152(6). PMID: 23498938    Free PMC article.
Highly Cited. Review.
A long non-coding RNA signature to improve prognosis prediction of gastric cancer.
Xiaoqiang Zhu, Xianglong Tian, +6 authors, Haoyan Chen.
Mol Cancer, 2016 Sep 21; 15(1). PMID: 27647437    Free PMC article.
Highly Cited.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, +3 authors, Ahmedin Jemal.
CA Cancer J Clin, 2018 Sep 13; 68(6). PMID: 30207593
Highly Cited.
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β.
Martina Rossi, Gabriele Bucci, +12 authors, Roberto Gherzi.
Nat Commun, 2019 May 01; 10(1). PMID: 31036808    Free PMC article.
Factors predicting late recurrence for estrogen receptor-positive breast cancer.
Ivana Sestak, Mitch Dowsett, +4 authors, Jack Cuzick.
J Natl Cancer Inst, 2013 Sep 14; 105(19). PMID: 24029245    Free PMC article.
Highly Cited.
Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Qiu-Jie Zhao, Jiao Zhang, Lin Xu, Fang-Feng Liu.
World J Gastroenterol, 2018 Aug 21; 24(30). PMID: 30122881    Free PMC article.
miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL Study.
Loki Natarajan, Minya Pu, +10 authors, Karen Messer.
Cancer Epidemiol Biomarkers Prev, 2019 Jun 13; 28(9). PMID: 31186261    Free PMC article.
Long noncoding RNA BCAR4 promotes glioma cell proliferation via EGFR/PI3K/AKT signaling pathway.
Lian Wei, Zhao Yi, Kongyan Guo, Xu Long.
J Cell Physiol, 2019 Jun 08; 234(12). PMID: 31173355
Researchers find discordance between standard human epidermal growth factor receptor 2 (HER2) testing and HER2 status reported on Oncotype DX.
Mary Kay Barton.
CA Cancer J Clin, 2012 Jan 20; 62(2). PMID: 22259018